Litcius/Paper detail

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Annika Fendler, Scott T.C. Shepherd, Lewis Au, Katalin A. Wilkinson, Mary Wu, Andreas M. Schmitt, Zayd Tippu, Sheima Farag, Aljosja Rogiers, Ruth Harvey, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, Karla Lingard, Mary Mangwende, Lucy Holt, Hamid Ahmod, Justine Korteweg, Tara Foley, Taja Barber, Andrea Emslie-Henry, Niamh Caulfield-Lynch, Fiona Byrne, Benjamin Shum, Camille L. Gérard, Daqi Deng, Svend Kjær, Ok‐Ryul Song, Christophe J. Queval, Caitlin Kavanagh, Emma Wall, Edward J Carr, Sina Namjou, Simon Caidan, Mike Gavrielides, James I. MacRae, Gavin Kelly, Kema Peat, Denise Kelly, Aida Murra, Kayleigh Kelly, Molly O’Flaherty, Robyn Shea, Gail Gardner, Darren R. Murray, Sanjay Popat, Nadia Yousaf, Shaman Jhanji, Nicholas van As, Kate Young, Andrew J.S. Furness, Lisa Pickering, Rupert Beale, Charles Swanton, Sonia Gandhi, S.J. Gamblin, David L.V. Bauer, George Kassiotis, Michael Howell, Emma Nicholson, Susanna Walker, Robert J. Wilkinson, James Larkin, Samra Turajlic

2022Cancer Cell19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCancerImmune systemVaccinationImmunologyCoronavirus disease 2019 (COVID-19)AntibodyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses